Skip to Content
Merck
All Photos(2)

Documents

MAK150

Sigma-Aldrich

Fluorometric Intracellular pH Assay Kit

sufficient for 1000 fluorometric tests

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12161503
NACRES:
NA.84

usage

sufficient for 1000 fluorometric tests

detection method

fluorometric

relevant disease(s)

neurological disorders; genitourinary disorders; cancer

storage temp.

−20°C

General description

Intracellular pH changes are implicated in diverse physiological and pathological processes, including cell proliferation, apoptosis, fertilization, malignancy, multidrug resistance, ion transport, lysosomal storage disorders, and Alzheimer′s disease.

This kit can be utilized to measure decreases in intracellular pH in cells treated under various conditions using a simple standard protocol. Alternatively, an Acid-Load procedure can be used to measure the increase of intracellular pH associated with changes in cellular metabolism due to GPCR activation, growth factor activity, or other cellular stimulation. With the Acid-Load procedure ammonium chloride solution is added after the fluorescent pH dye is loaded into cells in a minimum volume. This Acid-Loading step is followed by the addition of agonist in a relatively large volume (~4x) of buffer. The sudden volume change initiates an efflux of ammonia (NH3) from the cells causing a rapid decrease in intracellular pH, and thus a decrease in fluorescence signal. The effect of agonist on the subsequent recovery of intracellular pH is measured by the relative fluorescence signal increase.

Application

Fluorometric Intracellular pH Assay Kit has been used to measure the intracellular pH.

Features and Benefits

Superior alternative to BCECF

Suitability

This kit can be utilized to measure changes in intracellular pH in cells treated under various conditions.

Principle

The Fluorometric Intracellular pH Assay Kit utilizes a proprietary cell-permeable fluorescent indicator, BCFL-AM, for measuring relative intracellular pH changes. BCFL-AM is a superior alternative to the popular ratiometric pH probe, 2′,7′-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF). Unlike BCECF, which is a complex and variable mixture of isomers, BCFL-AM is a single isomer species. BCFL-AM has the same spectral responses as BCECF-AM (λex = 490 nm/λem = 535 nm for single measurement or λex = 505 nm/λem = 535 nm and λex = 430 nm/λem = 535 nm for ratio measurement) but enhanced reproducibility. BCFL-AM exhibits pH-dependent dual excitability, pKa ~7.0, and an excitation isosbestic point of 454 nm.

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.
Koyuncu I, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry, 33(1), 1137-1149 (2018)
Shawn C Chafe et al.
Science advances, 7(35) (2021-08-29)
The metabolic mechanisms involved in the survival of tumor cells within the hypoxic niche remain unclear. We carried out a synthetic lethal CRISPR screen to identify survival mechanisms governed by the tumor hypoxia-induced pH regulator carbonic anhydrase IX (CAIX). We
Besa Emini Veseli et al.
FEBS letters, 594(18), 3067-3075 (2020-07-04)
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 (PFKFB3) is a key enzyme of the glycolytic pathway, and it plays an essential role in angiogenesis. 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) is frequently used as a glycolysis inhibitor and is thought to inhibit PFKFB3. However, this latter effect of
Shawn C Chafe et al.
Cancer immunology research, 7(7), 1064-1078 (2019-05-16)
Treatment strategies involving immune-checkpoint blockade (ICB) have significantly improved survival for a subset of patients across a broad spectrum of advanced solid cancers. Despite this, considerable room for improving response rates remains. The tumor microenvironment (TME) is a hurdle to

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service